E-LIB Suche - Ergebnisse für: Bonvoisin, B.

1

Additive manufacturing based bellows:

Bonvoisin, B. ; Brandao, A. ; Hatzenbichler, M....
CEAS Space Journal. 15 (2022) 1 - p. 27-35 , 2022

Link: https://doi.org/10.1007/..

2

Demisability assessment of space materials:

Bonvoisin, B. ; Meisnar, M. ; Merrifield, J....
CEAS Space Journal. 15 (2022) 1 - p. 213-235 , 2022

Link: https://doi.org/10.1007/..

3

About the demisability of propellant tanks during atmospher..:

Lips, T. ; Fritsche, B. ; Kanzler, R....
Journal of Space Safety Engineering. 4 (2017) 2 - p. 99-104 , 2017

Link: https://doi.org/10.1016/..

4

Histomorphometric evaluation of daily and intermittent oral..:

Recker, R. R. ; Weinstein, R. S. ; Chesnut III, C. H....
Osteoporosis International. 15 (2004) 3 - p. 231-237 , 2004

Link: https://doi.org/10.1007/..

5

Prevention of early postmenopausal bone loss with oral tilu..:

Roux, C. ; Deroisy, R. ; Basse-Cathalinat, B....
Osteoporosis International. 6 (1996) S1 - p. 249-249 , 1996

Link: https://doi.org/10.1007/..

6

Bacterial endocarditis presenting as acute vertebral osteom..:

Ninet, J. ; Gayet, J. L. ; Etienne, J....
European Heart Journal. 5 (1984) suppl C - p. 101-105 , 1984

Link: https://doi.org/10.1093/..

7

Les insuffisances aortiques de la spondylarthrite ankylosan..:

Ninet, J. ; Delahaye, J.-P. ; Pasquier, J....
La Revue de Médecine Interne. 4 (1983) 1 - p. 94-104 , 1983

Link: https://doi.org/10.1016/..

8

Efficacy and tolerability of once-monthly oral ibandronate ..:

Reginster, Jean-Yves ; Adami, S ; Lakatos, P...
urn:issn:0003-4967. , 2006

Link: https://orbi.uliege.be/h..

9

Efficacy and tolerability of once‐monthly oral ibandronate ..:

Reginster, J‐Y ; Adami, S ; Lakatos, P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798147. , 2006

Link: http://www.ncbi.nlm.nih...

10

Once-monthly and daily oral ibandronate are at least as eff..:

Reginster, Jean-Yves ; Lorenc, R ; Stepan, J. J...
urn:issn:0003-4967. , 2005

Link: https://orbi.uliege.be/h..

11

Monthly oral ibandronate is well tolerated and efficacious ..:

Reginster, Jean-Yves ; Wilson, K. M ; Dumont, Etienne..
urn:issn:0021-972X. , 2005

Link: https://orbi.uliege.be/h..

12

Two-year efficacy and tolerability of once-monthly oral iba..:

Cooper, C ; Delmas, P. D ; Felsenberg, D...
urn:issn:0003-4967. , 2005

Link: https://orbi.uliege.be/h..

13

Oral monthly ibandronate: rationale and clinical potential ..:

Reginster, Jean-Yves ; McClung, M ; Coutant, K...
urn:issn:0003-4967. , 2003

Link: https://orbi.uliege.be/h..

14

Increased DNA and/or RNA content of synovial fluid cells in..:

Bonvoisin, B ; Cordier, G ; Revillard, J P..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1001469. , 1984

Link: http://www.ncbi.nlm.nih...

15

Son A. R. - Madame, Duchesse - D'Angoulême Née à Versailles..:

Bonvoisin, H. Graveur ; Bonvoisin, B. Dessinateur du modèle
Notice de recueil : http://catalogue.bnf.fr/ark:/12148/cb387930813. , 1816

Link: http://gallica.bnf.fr/ar..